Whole Body Health Sale

Seasonal Affective Disorder References

Disease Prevention and Treatment, 5th edition

The references on this page correspond with the print version of Disease Prevention and Treatment, 5th edition. Since we continuously update the protocols online in response to new scientific developments, readers are encouraged to review the latest versions of the protocols.

  1. Ford K. A seasonal depression: Management of seasonal affective disorder. Prof Nurse. 1992;8(2):94–8.
  2. Magnusson A, Boivin D. Seasonal affective disorder: An overview. Chronobiol Int. 2003;20(2):189–207.
  3. Magnusson A, Partonen T. The diagnosis, symptomatology, and epidemiology of seasonal affective disorder. CNS Spectr. 2005 Aug;10(8):625–34;quiz 1–14. Review.
  4. Rosenthal NE, Sack DA, et al. Seasonal affective disorder: A description of the syndrome and preliminary findings with light therapy. Arch Gen Psychiatry. 1984;41(1):72–80.
  5. Sher L. Genetic studies of seasonal affective disorder and seasonality. Compr Psychiatry. 2001;42(2):105–10.
  6. Gross F, Gysin F. [Phototherapy in psychiatry: clinical update and review of indications]. Encephale. 1996;22(2):143–8.
  7. Rosen LN, Targum SD, et al. Prevalence of seasonal affective disorder at four latitudes. Psychiatry Res. 1990 Feb;31(2):131-44.
  8. Madden PA, Heath AC, et al. Seasonal changes in mood and behavior: The role of genetic factors. Arch Gen Psychiatry. 1996;53(1):47–55.
  9. Allen JM, Lam RW, et al. Depressive symptoms and family history in seasonal and nonseasonal mood disorders. Am J Psychiatry. 1993;150(3):443–8.
  10. Thompson C, Isaacs G. Seasonal affective disorder—a British sample: Symptomatology in relation to mode of referral and diagnostic subtype. J Affect Disord. 1988;14(1):1–11.
  11. White DM, Lewy AJ, et al. Is winter depression a bipolar disorder? Compr Psychiatry. 1990;31(3):196–204.
  12. Wirz-Justice A, Bucheli C, et al. Light treatment of seasonal affective disorder in Switzerland. Acta Psychiatr Scand. 1986;74(2):193–204.
  13. Hirota T, Fukada Y. Resetting mechanism of central and peripheral circadian clocks in mammals. Zoolog Sci. 2004;21(4):359–68.
  14. Winton F, Corn T, et al. Effects of light treatment upon mood and melatonin in patients with seasonal affective disorder. Psychol Med. 1989;19(3):585–90.
  15. Checkley SA, Murphy DG, et al. Melatonin rhythms in seasonal affective disorder. Br J Psychiatry. 1993;163:332–7.
  16. Partonen T, Vakkuri O, et al. Effects of bright light on sleepiness, melatonin, and 25-hydroxyvitamin D(3) in winter seasonal affective disorder. Biol Psychiatry. 1996;39(10):865–72.
  17. Schlager DS. Early-morning administration of short-acting beta blockers for treatment of winter depression. Am J Psychiatry. 1994;151(9):1383–5.
  18. Hebert M, Beattie CW, et al. Electroretinography in patients with winter seasonal affective disorder. Psychiatry Res. 2004;127(1–2):27–34.
  19. Terman JS, Terman M. Photopic and scotopic light detection in patients with seasonal affective disorder and control subjects. Biol Psychiatry. 1999;46(12):1642–8.
  20. Leu SJ, Shiah IS, et al. Immune-inflammatory markers in patients with seasonal affective disorder: Effects of light therapy. J Affect Disord. 2001;63(1–3):27–34.
  21. Stastny J, Konstantinidis A, et al. Effects of tryptophan depletion and catecholamine depletion on immune parameters in patients with seasonal affective disorder in remission with light therapy. Biol Psychiatry. 2003;53(4):332–7.
  22. Hoekstra R, Fekkes D, et al. Effect of light therapy on biopterin, neopterin and tryptophan in patients with seasonal affective disorder. Psychiatry Res. 2003;120(1):37–42.
  23. Jepson TL, Ernst ME, et al. Current perspectives on the management of seasonal affective disorder. J Am Pharm Assoc (Wash). 1999;39(6):822–9.
  24. Schwartz PJ, Murphy DL, et al. Effects of meta-chlorophenylpiperazine infusions in patients with seasonal affective disorder and healthy control subjects. Diurnal responses and nocturnal regulatory mechanisms. Arch Gen Psychiatry. 1997;54(4):375–85.
  25. Depue RA, Arbisi P, et al. Seasonal and mood independence of low basal prolactin secretion in premenopausal women with seasonal affective disorder. Am J Psychiatry. 1989;146(8):989–95.
  26. Depue RA, Arbisi P, et al. Seasonal independence of low prolactin concentration and high spontaneous eye blink rates in unipolar and bipolar II seasonal affective disorder. Arch Gen Psychiatry. 1990;47(4):356–64.
  27. Carlsson A, Svennerholm L, et al. Seasonal and circadian monoamine variations in human brains examined post mortem. Acta Psychiatr Scand Suppl. 1980;280:75–85.
  28. Lam RW, Levitan RD. Pathophysiology of seasonal affective disorder: A review. J Psychiatry Neurosci. 2000a;25(5):469–80.
  29. Lambert GW, Reid C, et al. Effect of sunlight and season on serotonin turnover in the brain. Lancet. 2002;360(9348):1840–2.
  30. Lansdowne AT, Provost SC. Vitamin D3 enhances mood in healthy subjects during winter. Psychopharmacology (Berl). 1998;135(4):319–23.
  31. Lam RW, Bowering TA, et al. Effects of rapid tryptophan depletion in patients with seasonal affective disorder in natural summer remission. Psychol Med. 2000b;30(1):79–87.
  32. Eastman CI, Young MA, et al. Bright light treatment of winter depression: A placebo-controlled trial. Arch Gen Psychiatry. 1998;55(10):883–9.
  33. Lewy AJ, Bauer VK, et al. Morning vs evening light treatment of patients with winter depression. Arch Gen Psychiatry. 1998b;55(10):890–6.
  34. Pjrek E, Winkler D, et al. Bright light therapy in seasonal affective disorder—does it suffice? Eur Neuropsychopharmacol. 2004;14(4):347–51.
  35. Lewy AJ, Sack RL, et al. Antidepressant and circadian phase-shifting effects of light. Science. 1987a;235(4786):352–4.
  36. Lewy AJ, Sack RL, et al. The phase shift hypothesis for bright light’s therapeutic mechanism of action: Theoretical considerations and experimental evidence. Psychopharmacol Bull. 1987b;23(3):349–53.
  37. Terman JS, Terman M, et al. Circadian time of morning light administration and therapeutic response in winter depression. Arch Gen Psychiatry. 2001;58(1):69–75.
  38. Lam RW, Gorman CP, et al. Multicenter, placebo-controlled study of fluoxetine in seasonal affective disorder. Am J Psychiatry. 1995;152(12):1765–70.
  39. Moscovitch A, Blashko CA, et al. A placebo-controlled study of sertraline in the treatment of outpatients with seasonal affective disorder. Psychopharmacology (Berl). 2004;171(4):390–7.
  40. Potter W, Hollister L. Antidepressant agents. In Katzung B, ed. Basic & Clinical Pharmacology. 8th ed. New York, NY: McGraw-Hill; 2001:498–511.
  41. Childs PA, Rodin I, et al. Effect of fluoxetine on melatonin in patients with seasonal affective disorder and matched controls. Br J Psychiatry. 1995;166(2):196–8.
  42. Kasper S, el Giamal N, et al. Reboxetine: The first selective noradrenaline re-uptake inhibitor. Expert Opin Pharmacother. 2000;1(4):771–82.
  43. Hilger E, Willeit M, et al. Reboxetine in seasonal affective disorder: An open trial. Eur Neuropsychopharmacol. 2001;11(1):1–5.
  44. Lundt L. Modafinil treatment in patients with seasonal affective disorder/winter depression: An open-label pilot study. J Affect Disord. 2004;81(2):173–8.
  45. Scammell TE, Estabrooke IV, et al. Hypothalamic arousal regions are activated during modafinil-induced wakefulness. J Neurosci. 2000;20(22):8620–28.
  46. DeBattista C, Doghramji K, et al. Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: A preliminary double-blind, placebo-controlled study. J Clin Psychiatry. 2003;64(9):1057–64.
  47. Menza MA, Kaufman KR, et al. Modafinil augmentation of antidepressant treatment in depression. J Clin Psychiatry. 2000;61(5):378–81.
  48. Arendt J, Skene DJ. Melatonin as a chronobiotic. Sleep Med Rev. 2005;9(1):25–39.
  49. Macchi MM, Bruce JN. Human pineal physiology and functional significance of melatonin. Front Neuroendocrinol. 2004;25(3–4):177–95.
  50. Lewy AJ, Bauer VK, et al. Melatonin treatment of winter depression: A pilot study. Psychiatry Res. 1998a;77(1):57–61.
  51. Rohr UD, Herold J. Melatonin deficiencies in women. Maturitas. 2002;41(Suppl 1):S85–104.
  52. Birdsall TC. 5-Hydroxytryptophan: A clinically-effective serotonin precursor. Altern Med Rev. 1998;3(4):271–80.
  53. McKee T, McKee J. Nitrogen metabolism I: Synthesis. In Peterson K, Horn M, eds. Biochemistry—An Introduction. 2nd ed. New York, NY: McGraw-Hill; 1999:359–408.
  54. Ghadirian AM, Murphy BE, et al. Efficacy of light versus tryptophan therapy in seasonal affective disorder. J Affect Disord. 1998;50(1):23–7.
  55. Lam RW, Zis AP, et al. Effects of rapid tryptophan depletion in patients with seasonal affective disorder in remission after light therapy. Arch Gen Psychiatry. 1996;53(1):41–4.
  56. Lam RW, Levitan RD, et al. L-tryptophan augmentation of light therapy in patients with seasonal affective disorder. Can J Psychiatry. 1997;42(3):303–6.
  57. Maini RN, Taylor PC, et al. Insights into the pathogenesis of rheumatoid arthritis from application of anti-TNF therapy. Nihon Rinsho Meneki Gakkai Kaishi. 2000;23(6):487–9.
  58. McGeer PL, McGeer EG. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Brain Res Rev. 1995 Sep;21(2):195-218. Review.
  59. Thornton AE, Raz N. Memory impairment in multiple sclerosis: A quantitative review. Neuropsychology. 1997;11(3):357–66.
  60. Das YT, Bagchi M, et al. Safety of 5-hydroxy-L-tryptophan. Toxicol Lett. 2004 Apr 15;150(1):111–22. Review.
  61. Guilleminault C, Cathala JP, et al. Effects of 5-hydroxytryptophan on sleep of a patient with a brain-stem lesion. Electroencephalogr Clin Neurophysiol. 1973;34(2):177–84.
  62. Soulairac A, Lambinet H. [Effect of 5-hydroxytryptophan, a serotonin precursor, on sleep disorders]. Ann Med Psychol (Paris). 1977;1(5):792–8.
  63. Wyatt RJ, Zarcone V, et al. Effects of 5-hydroxytryptophan on the sleep of normal human subjects. Electroencephalogr Clin Neurophysiol. 1971 Jun;30(6):505-9.
  64. Jacobsen FM, Sack DA, et al. Neuroendocrine response to 5-hydroxytryptophan in seasonal affective disorder. Arch Gen Psychiatry. 1987 Dec;44(12):1086–91.
  65. Martin TG. Serotonin syndrome. Ann Emerg Med. 1996 Nov;28(5):520-6. Review.
  66. Hvas AM, Juul S, et al. Vitamin B6 level is associated with symptoms of depression. Psychother Psychosom. 2004;73(6):340–3.
  67. Touitou Y, Touitou C, et al. Serum magnesium circadian rhythm in human adults with respect to age, sex and mental status. Clin Chim Acta. 1978;87(1):35–41.
  68. Ising H, Bertschat F, et al. Measurement of free magnesium in blood, serum and plasma with an ion-sensitive electrode. Eur J Clin Chem Clin Biochem. 1995;33(6):365–71.
  69. Durlach J, Pages N, et al. Chronopathological forms of magnesium depletion with hypofunction or with hyperfunction of the biological clock. Magnes Res. 2002;15(3–4):263–8.
  70. Vorbach EU, Arnoldt KH, Hubner WD. Efficacy and tolerability of St. John's wort extract LI 160 versus imipramine in patients with severe depressive episodes according to ICD-10. Pharmacopsychiatry. 1997 Sep;30 Suppl 2:81-5.
  71. Kasper S. Treatment of seasonal affective disorder (SAD) with hypericum extract. Pharmacopsychiatry. 1997;30(Suppl 2): 89–93.
  72. Martinez B, Kasper S, et al. Hypericum in the treatment of seasonal affective disorders. J Geriatr Psychiatry Neurol. 1994;7(Suppl 1):S29-S33.
  73. Nangia M, Syed W, et al. Efficacy and safety of St. John’s wort for the treatment of major depression. Public Health Nutr. 2000;3(4A):487–94.
  74. McGrath-Hanna NK, Greene DM, et al. Diet and mental health in the Arctic: Is diet an important risk factor for mental health in circumpolar peoples?—a review. Int J Circumpolar Health. 2003 Sep;62(3):228–41. Review.
  75. Cott J, Hibbeln JR. Lack of seasonal mood change in Icelanders. Am J Psychiatry. 2001 Feb;158(2):328.
  76. Magnusson A, Axelsson J, et al. Lack of seasonal mood change in the Icelandic population: Results of a cross-sectional study. Am J Psychiatry. 2000 Feb;157(2):234–8.